secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-042836
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty closes acquisition of Generation Bio for $4.2913/share plus CVR
----------------------------------------------------------------------------

- Completed tender offer; 4,722,533 shares (approx. 70%) tendered, all accepted.
- Acquisition closed Feb 9, 2026; Generation Bio becomes wholly owned subsidiary.
- CVRs entitle holders to 70-100% of Net Cash Excess and tiered shares of Legacy Assets and Moderna Collaboration proceeds.
- Binney Lease arrangement allocates up to $30M for future lease payments; excess may flow to CVR holders.
- Legacy Assets Transaction Proceeds range from 70% (Year 1-2) to 30% (Year 7-10) of Net Proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312526042836/0001193125-26-042836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312526042836/d59988d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-042836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer